Navigation Links
Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
Date:10/16/2007

Company Plans to File Supplemental New Drug Application with FDA in First

Quarter 2008

SOUTH SAN FRANCISCO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced positive top-line results from its pivotal Phase 3 trial. The multi-center, randomized, double-blind study with 699 adult patients met its primary endpoint, demonstrating less venous procedural pain in those treated with Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system compared to placebo (p= 0.003). Patients received Zingo or placebo one to three minutes prior to undergoing venous access procedures (IV insertions or blood draws). Zingo was found to be well tolerated in this patient population. Anesiva plans to file a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) in the first quarter of 2008 for the use of Zingo in adults.

"We've now shown that Zingo works in both the pediatric and adult populations. An expanded label from the FDA to include adults could greatly expand the market opportunity for us," said John P. McLaughlin, chief executive officer of Anesiva. "We have a world-class commercialization team that has significant efforts underway to prime the market for Zingo's introduction to pediatric hospitals in order to prepare for a strong launch and the development of a very successful business."

Zingo is already approved by the FDA to provide local analgesia prior to venipuncture or peripheral intravenous cannulation in children three to 18 years of age. Its onset of action is one to three minutes. Venous access procedures are among the most common procedures performed at a hospital, with more th
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... und TÜBINGEN, Deutschland, 5. März 2015 /PRNewswire/ ... und das deutsche biopharmazeutische Unternehmen CureVac geben ... Euro (52 Millionen US-Dollar) in CureVac investiert. ... medizinisch angewandten Messenger-RNA (mRNA). Auf Basis dieses ... Behandlung von Krankheiten und zum Schutz vor ...
(Date:3/5/2015)... , March 5, 2015 Bayer HealthCare announced ... the Conquer Cancer Foundation of the American Society of ... health information technology platform designed to unlock vast quantities ... cancer.  "Bayer is proud to join ... to leverage Big Data to help people whose lives ...
(Date:3/5/2015)...  Medical Diagnostic Laboratories, L.L.C., (MDL), a CLIA-certified, ... automated DNA-based molecular analyses, announces that it is ... utilizes cutting edge technology, including next- generation DNA ... women are diagnosed with cervical cancer in ... Papillomaviruses (HPV) are a group of more than ...
Breaking Medicine Technology:Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... and LOS ANGELES , July 21 /PRNewswire-Asia/ ... or,the "Company"), one of the leading health products distribution and ... of seven new chain,drugstores in July. These new openings ... City, 31 in Baishan City, and a total of ...
... CHARLOTTE, N.C. , July 21 /PRNewswire-FirstCall / -- ... has completed the acquisition of the Anhydro business, a Soeborg, ... and dewatering plants and equipment.  The terms of the transaction were ... , ...
Cached Medicine Technology:China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 2China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 3China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 4SPX Completes Acquisition of Anhydro 2SPX Completes Acquisition of Anhydro 3
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a ... repair market, reported record revenue of $4.79 million for ... $2.98 million in the year-ago fourth quarter demonstrating the ... “Our strong fourth quarter revenue growth reflects the market’s ... is driving increased surgeon adoption of our unique product ...
(Date:3/5/2015)... HomeCEUConnection.com is proud to support ... on their nutrition CEUs. To raise awareness ... HomeCEUConnection.com is offering 10% off selected nutrition ... NUTRITION2015 . , High Quality Continuing Education ... high-quality continuing education courses for Physical Therapists, ...
(Date:3/5/2015)... TCS Healthcare Technologies (TCS), a leading ... health management arena, is pleased to announce a webinar ... Advanced Care™ (ACUITY) version 7.20. The session will focus ... advantages of automation. , The webinar, scheduled for March ... by Jeff Frater, RN, BSN, Director of Partner Development ...
(Date:3/5/2015)... Portland, Ore. (PRWEB) March 05, 2015 ... health sciences university founded in 1904, has launched ... behaviors and positive lifestyle changes. The Northwest Center ... educate health professionals, support community outreach, and conduct ... promotion, functional medicine, diet and nutrition. The center ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 INTEGRATED ... healthcare organizations to participate in its 2015 Children’s ... from executive and director-level positions, and the survey ... Last year’s report featured data on 60 executive ... children’s healthcare organizations and 7 subsidiary children’s hospitals. ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2
... Reinberg HealthDay Reporter , TUESDAY, Nov. 30 (HealthDay News) ... more vitamin D, a new report from the Institute of Medicine ... day. The IOM did bump up the recommended dietary ... report, released 13 years ago. , , For many people, 600 ...
... (HealthDay News) -- Early assessment of rheumatoid arthritis can ... likelihood of disease remission without having to take disease-modifying ... Although DMARDs are considered effective in treating rheumatoid arthritis, ... linked to uncommon but serious side effects. The ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... model, researchers say they,ve determined that relying on "active ... a "reasonable approach" and alternative to immediate treatment, which ... impotence. If the tumor were to start growing ...
... American Society of Hematology (ASH) recognizes the following abstract ... in Orlando, FL, with the highest scoring abstracts in ... resident physician, and post-doctoral fellow. Merit Award winners receive ... The 2010 Merit Award recipients are: ...
... In what might be one of the world,s first ... that they have successfully implanted an experimental device in the ... control his ability to swallow. The device, which could offer ... problems, is controlled by pulling on a tiny metal pin ...
... Nov. 30, 2010 The latest episode in the ... Challenges/Chemistry Solutions ," focuses on the discovery that black ... is the staple food for one-third of the world,s ... allergies, asthma and other diseases. In the ...
Cached Medicine News:Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 2Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 3Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 4Health News:Better Outcomes Seen With Early Rheumatoid Arthritis Diagnosis 2Health News:Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer 2Health News:Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer 3Health News:ASH announces 2010 merit award winners 2Health News:UC Davis surgeons test innovative device in patient with swallowing disorder 2Health News:UC Davis surgeons test innovative device in patient with swallowing disorder 3
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes....
... Enhanced features including aspiration holes and ... laparoscopic procedures requiring precise dissection with ... increased suction demands. ,Flexible design ... and nonretractable electrodes and multiple tip ...
... including aspiration holes and additional electrode ... requiring precise dissection with decreased risk ... demands. ,Flexible design options allow ... electrodes and multiple tip designs. Optimize ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: